Multivariate analysis: factors affecting transplantation outcome
Group . | Relative ratio (95% CI) . | P . |
|---|---|---|
| All patients | ||
| Overall survival | ||
| Disease phase | 4.6 (1.9-10.9) | .001 |
| LC30 | 6.7 (1.3-34.1) | .02 |
| Current LFS | ||
| Disease phase | 3.4 (1.6-7.5) | .02 |
| LC30 | 13.2 (3.2-55.1) | < .001 |
| TRM | ||
| Disease phase | 2.9 (1.1-7.8) | .03 |
| PBSCT patients | ||
| Overall survival | ||
| Disease phase | 9.7 (2.6-36) | .001 |
| LC30 | 5.8 (1.1-31.6) | .04 |
| Current LFS | ||
| Disease phase | 5.3 (1.9-14.5) | .001 |
| LC30 | 13.7 (3.1-59.7) | <.001 |
| TRM | ||
| Disease phase | 7.8 (1.6-38.8) | .01 |
Group . | Relative ratio (95% CI) . | P . |
|---|---|---|
| All patients | ||
| Overall survival | ||
| Disease phase | 4.6 (1.9-10.9) | .001 |
| LC30 | 6.7 (1.3-34.1) | .02 |
| Current LFS | ||
| Disease phase | 3.4 (1.6-7.5) | .02 |
| LC30 | 13.2 (3.2-55.1) | < .001 |
| TRM | ||
| Disease phase | 2.9 (1.1-7.8) | .03 |
| PBSCT patients | ||
| Overall survival | ||
| Disease phase | 9.7 (2.6-36) | .001 |
| LC30 | 5.8 (1.1-31.6) | .04 |
| Current LFS | ||
| Disease phase | 5.3 (1.9-14.5) | .001 |
| LC30 | 13.7 (3.1-59.7) | <.001 |
| TRM | ||
| Disease phase | 7.8 (1.6-38.8) | .01 |
Comparisons were between chronic versus advanced phase and LC30 greater than or less than 0.30 × 109/L. Chronic phase and LC30 above 0.30 × 109/L were considered favorable factors, while advanced phase and LC30 below 0.30 × 109/L were considered unfavorable.